chr12-56716195-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001365896.1(NACA):c.5335G>A(p.Glu1779Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,682 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001365896.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NACA | NM_001365896.1 | c.5335G>A | p.Glu1779Lys | missense_variant | 3/9 | ENST00000454682.6 | NP_001352825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NACA | ENST00000454682.6 | c.5335G>A | p.Glu1779Lys | missense_variant | 3/9 | 5 | NM_001365896.1 | ENSP00000403817.1 | ||
ENSG00000285625 | ENST00000647707.1 | c.512-1508G>A | intron_variant | ENSP00000497880.1 | ||||||
NACA | ENST00000547914.5 | n.71-1508G>A | intron_variant | 5 | ENSP00000446745.1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152168Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000604 AC: 15AN: 248312Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135080
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461396Hom.: 1 Cov.: 46 AF XY: 0.0000165 AC XY: 12AN XY: 726962
GnomAD4 genome AF: 0.000250 AC: 38AN: 152286Hom.: 0 Cov.: 31 AF XY: 0.000269 AC XY: 20AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.1876G>A (p.E626K) alteration is located in exon 5 (coding exon 4) of the NACA gene. This alteration results from a G to A substitution at nucleotide position 1876, causing the glutamic acid (E) at amino acid position 626 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at